Literature DB >> 25810295

Coronary heart disease risk factors take a disproportional toll on women.

Michael Holinstat1, Benjamin E Tourdot2.   

Abstract

Entities:  

Keywords:  platelets; receptor pharmacology; risk factors; signal transduction; thrombosis

Mesh：

Substances：

Year:  2015        PMID： 25810295      PMCID： PMC4377641          DOI： 10.1161/ATVBAHA.115.305466

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  9 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  Toll-like receptor 4 signal transduction in platelets: novel pathways.

Authors:  Julien Berthet; Pauline Damien; Hind Hamzeh-Cognasse; Bruno Pozzetto; Olivier Garraud; Fabrice Cognasse
Journal:  Br J Haematol       Date:  2010-07-07       Impact factor: 6.998

3.  Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4.

Authors:  Fabrizio Semeraro; Concetta T Ammollo; James H Morrissey; George L Dale; Paul Friese; Naomi L Esmon; Charles T Esmon
Journal:  Blood       Date:  2011-06-14       Impact factor: 22.113

4.  Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.

Authors:  Milka Koupenova; Olga Vitseva; Christopher R MacKay; Lea M Beaulieu; Emelia J Benjamin; Eric Mick; Evelyn A Kurt-Jones; Katya Ravid; Jane E Freedman
Journal:  Blood       Date:  2014-04-22       Impact factor: 22.113

5.  Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo.

Authors:  Rukhsana Aslam; Edwin R Speck; Michael Kim; Andrew R Crow; K W Annie Bang; Frederick P Nestel; Heyu Ni; Alan H Lazarus; John Freedman; John W Semple
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

6.  Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis.

Authors:  Soumya Panigrahi; Yi Ma; Li Hong; Detao Gao; Xiaoxia Z West; Robert G Salomon; Tatiana V Byzova; Eugene A Podrez
Journal:  Circ Res       Date:  2012-10-15       Impact factor: 17.367

Review 7.  Platelets as cellular effectors of inflammation in vascular diseases.

Authors:  Matthew T Rondina; Andrew S Weyrich; Guy A Zimmerman
Journal:  Circ Res       Date:  2013-05-24       Impact factor: 17.367

8.  Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase.

Authors:  Price Blair; Sybille Rex; Olga Vitseva; Lea Beaulieu; Kahraman Tanriverdi; Subrata Chakrabarti; Chie Hayashi; Caroline A Genco; Mark Iafrati; Jane E Freedman
Journal:  Circ Res       Date:  2008-12-23       Impact factor: 17.367

9.  The toll-like receptor 2/1 (TLR2/1) complex initiates human platelet activation via the src/Syk/LAT/PLCγ2 signalling cascade.

Authors:  Knut Fälker; Kristin Klarström-Engström; Torbjörn Bengtsson; Tomas L Lindahl; Magnus Grenegård
Journal:  Cell Signal       Date:  2013-11-12       Impact factor: 4.315
  9 in total
  2 in total

Review 1.  Normal platelet function.

Authors:  Michael Holinstat
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

Review 2.  Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.

Authors:  Jennifer Yeung; Wenjie Li; Michael Holinstat
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.